Preeclampsia and Fetal Growth Restriction: From Prediction to Prevention

Wednesday, January 27, 2027 at 11:30 AM to 12:00 PM · 30 min. (Europe/London)
Women & Children's Health Stage
Day 1 - Wednesday 27th January
Women & Children's Health

Information

  • How longitudinal cohort studies and multi-omic profiling across pregnancy are helping identify placental biomarkers linked to complications such as preeclampsia and fetal growth restriction before symptoms develop  
  • Using proteomics, RNA and metabolite analysis to better understand the biological mechanisms underpinning abnormal placental development and adverse pregnancy outcomes  
  • The role of single-cell and spatial transcriptomic technologies in uncovering the cellular drivers of placental dysfunction and disease progression  
  • How earlier biological insight could enable predictive pregnancy medicine and open new opportunities for preventative intervention and targeted therapeutics in maternal-fetal healthcare.